SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-21-045039
Filing Date
2021-08-26
Accepted
2021-08-26 16:15:56
Documents
2
Period of Report
2021-10-05

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea146449-def14a_aikidopharma.htm DEF 14A 303003
2 GRAPHIC image_001.jpg GRAPHIC 20845
  Complete submission text file 0001213900-21-045039.txt   333161
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-05576 | Film No.: 211212533
SIC: 8731 Services-Commercial Physical & Biological Research